In vitro activity of clarithromycin in combination with other antimicrobial agents against biofilm-forming Pseudomonas aeruginosa strains

Acta Microbiologica et Immunologica Hungarica

Volumn 57, Issue 3, 2010, Pages 235-245

  Kádár, Béla ^a   Szasz M ^a   Kristóf, Katalin ^b   Pesti, Natasa ^b   Krizsan G ^a   Szentandrássy, Julianna ^c   Rokusz L ^c   Nagy, K ^a   Szabó, Dóra ^a  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c State Health Center   (Hungary)

Author keywords

beta lactam; biofilm; chlarithromycin; Pseudomonas aeruginosa; synergy

Indexed keywords

AMIKACIN; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; CLARITHROMYCIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; NETILMICIN; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN; ANTIINFECTIVE AGENT;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BIOFILM; CONTROLLED STUDY; DRUG POTENTIATION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; DRUG EFFECTS; HUMAN; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PHYSIOLOGY; PSEUDOMONAS INFECTION;

PSEUDOMONAS AERUGINOSA;

ANTI-BACTERIAL AGENTS; BIOFILMS; CLARITHROMYCIN; HUMANS; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 77957572207     PISSN: 12178950     EISSN: 15882640     Source Type: Journal    
DOI: 10.1556/AMicr.57.2010.3.8     Document Type: Article

References (23)

1. Hoštacká, A., Ciznár, I., Slobodníková , L., Kotulová, D.: Clinical Pseudomonas aeruginosa: potential factors of pathogenicity and resistance to antimicrobials. Folia Microbiol. 51, 633-638 (2006).
2. Harjai, K., Khandwaha, R. K., Mittal, R., Yadav, V., Gupta, V., Sharma, S.: Effect of pH on production of virulence factors by biofilm cells of Pseudomonas aeruginosa. Folia Microbiol. 50, 99-102 (2005).
3. Sugimura, M., Maseda, H., Hanaki, H., Nakae, T.: Macrolide antibiotic-mediated downregulation of MexAB-OprM efflux pump expression in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 52, 4141-4144 (2008).
4. Skindersoe, M. E., Alhede, M., Phipps, R., Yang, L., Jensen, P. O., Rasmussen, T. B., Bjarnsholt, T., Tolker-Nielsen, T., Høiby, N., Givskov, M.: Effects of antibiotics on quorum sensing in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 52, 3648-3663 (2008).
5. Høiby, N., Bjarnsholt, T., Givskov, M., Molin, S., Ciofu, O., Hoiby: Antibiotic resistance of bacterial biofilms. Int. J. Antimicrob. Agents 35, 322-332 (2010).
6. Clinical and Laboratory Standards Institute (CLSI). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 7th ed. Approved standard M7-A7. CLSI, Wayne, PA, 2006.
7. Cernohoska, L., Votava, M.: Determination of minimal regrowth concentration (MRC) in clinical isolates of various biofilm-forming bacteria. Folia Microbiol. 49, 75-78 (2004).
8. Song, W., Woo, L., Kim, J. S., Lee, K. M.: In vitro activity ofβ-lactams in combination with other antimicrobial agents against resistant strains of Pseudomonas aeruginosa. Internat. J. Antimicrob. Agents 21, 8-12 (2003).
9. Aaron, S. D., Ferris, W., Ramotar, K., Vandemheen, K., Chan, F., Saginur, R.: Single and combination antibiotic susceptibilities of planktonic, adherent, and biofilm-grown Pseudomonas aeruginosa isolates cultured from sputa of adults with cystic fibrosis. J. Clin. Microbiol. 40, 4172-4179 (2002).
10. Kobayashi, H.: Biofilm disease: Its clinical manifestation and therapeutic possibilities of macrolides. Am. J. Med. 99, 26S-30S (1995).
11. Mulet, X., Maciá, M. D., Mena, A., Juan, C., Pérez, J. L., Oliver, A.: Azithromycin in Pseudomonas aeruginosa biofilms: Bactericidal activity and selection of nfxB mutants. Antimicrob. Agents Chemother. 53, 1552-1560 (2009).
12. Garey, K. W., Vo, Q. P., Lewis, R. E., Saengcharoen, W., LaRocco, M. T., Tam, V. H.: Increased bacterial adherence and biomass in Pseudomonas aeruginosa bacteria exposed to clarithromycin. Diagn. Microbiol. Infect. Dis. 63, 81-86 (2009).
13. Nagata, T., Mukae, H., Kadota, J., Hayashi, T., Fujii, T., Kuroki, M., Shirai, R., Yanagihara, K., Tomono, K., Koji, T., Kohno, S.: Effect of erythromycin on chronic respiratory infection caused by Pseudomonas aeruginosa with biofilm formation in an experimental murine model. Antimicrob. Agents Chemother. 48, 2251-2259 (2004).
14. Tanaka, G., Shigeta, M., Komatsuzawa, H., Sugai, M., Suginaka H., Usui, T.: Effect of clarithromycin on Pseudomonas aeruginosa biofilms. Chemotherapy 46, 36-42 (2002).
15. Saiman, L., Mehar, F., Niu, W. W., Neu, H. C., Shaw, K. J., Miller, G., Prince, A.: Antibiotic susceptibility of multiply resistant Pseudomonas aeruginosa isolates from CF patients, including transplant candidates. Clin. Infect. Dis. 23, 532-537 (1996).
16. Kandemir, O., Oztuna, V., Milcan, A., Bayramoglu, A., Celik, H. H., Bayarslan, C., Kaya, A.: Clarithromycin destroys biofilms and enhances bactericidal agents in the treatment of Pseudomonas aeruginosa osteomyelitis. Clin. Orthop. Relat. Res. 430, 171-175 (2005).
17. Tré-Hardy, M., Vanderbist, F., Traore, H., Devleeschouwer, M. J.: In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures. Int. J. Antimicrob Agents 31, 329-336 (2008).
18. Saiman, L., Mehar, F., Niu, W. W., Neu, H. C., Shaw, K. J., Miller, G., Prince, A.: Antibiotic susceptibility of multiply resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis, including candidates for transplantation. Clin. Infect. Dis. 23, 532-537 (1996).
19. Saiman, L., Chen, Y., Gabriel, P. S., Knirsch, C.: Synergistic activities of macrolide antibiotics against Pseudomonas aeruginosa, Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans isolated from patients with cystic fibrosis. Antimicrob. Agents Chemother. 46, 1105-1107 (2002).
20. Bui, K. Q., Banevicius, M. A., Nightingale, C. H., Quintiliani, R., Nicolau, D. P.: In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa. J. Antimicrob. Chemother. 45, 57-62 (2000).
21. Giamarellos-Bourboulis, E. J., Antonopoulou, A., Raftogiannis, M., Koutoukas, P., Tsaganos T., Tziortzioti V., Panagou, C., Adamis, T., Giamarellou, H.: Clarithromycin is an effective immunomodulator when administered late in experimental pyelonephritis by multidrug-resistant Pseudomonas aeruginosa. BMC Infect. Dis. 6, 31 (2006).
22. Shinkai, M., Lopez-Boado, Y. S., Rubin, B. K.: Clarithromycin has an immunomodulatory effect on ERK-mediated inflammation induced by Pseudomonas aeruginosa flagellin. J. Antimicrob. Chemother. 59, 1096-1101 (2007).
23. Furuhata, M., Iwamura, M., Baba, S., Inoue, M.: Combined effect of clarithromycin and imipenem/cilastatin against urinary biofilm infection after pyeloplasty. Int. J. Urol. 10, 228-230 (2003).